Strong cash generation and balance sheet improvement
Generated MXN 8.1 billion in net cash from operating activities in 2025; cash and cash equivalents totaled MXN 10.8 billion and total debt fell to MXN 18.9 billion (down MXN 7.4 billion YoY). Adjusted net leverage improved to 0.9x (below target range). Free cash flow yield strengthened from 4% in 2019 to 14% at end of 2025.
Gross margin expansion and cost efficiency
Gross margin expanded to 55.2% in Q4 (up 110 basis points YoY), marking the eighth consecutive quarter of year-over-year gross margin expansion driven by lower agave-related input costs and strategic sourcing/manufacturing efficiencies.
EBITDA margin expansion and earnings resilience
Fourth-quarter EBITDA was flat year-on-year in absolute terms, while EBITDA margin expanded by 340 basis points to 24.4%, reflecting cost discipline (Distribution costs -6.5% and SG&A -6.2%) and other income gains (MXN 438 million) from contractual settlements.
Market share and volume outperformance in Mexico
In Mexico for 2025 the portfolio delivered volume growth of 2.5% and value growth of 2.0% versus industry declines (Total Spirits volume -1.4% and industry value -1.6%). Tequila category volume grew 2.5% while the company grew 3.9% in the category, underscoring continued leadership and share gains.
U.S. tequila outperformance and pricing discipline
Tequila category remained resilient (Nielsen: +2.3% volume in the year). Proximo outperformed the broader market with a smaller volume decline (-2.5%) versus category peers (~100 bps outperformance). Company limited average pricing decline to 5.1% vs category price decline of ~9.2%, prioritizing brand equity over aggressive discounting.
Rest of World and regional momentum
Rest of World business has doubled in net sales value since 2019. EMEA/APAC region sustained positive momentum in Q4 with APAC delivering double-digit depletions growth; full year EMEA/APAC shipments were flat and depletions increased 1.5%.
Long-term premiumization and historical growth
Since 2019 net revenues are up 45% (driven by 10% volume growth and 35% increase in average price per case). Average price per case has grown at a ~5% CAGR since 2019; gross profit has grown at a 7.5% CAGR and gross margin is +320 bps vs 2019, evidencing sustained premiumization and pricing power.